 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || KH617 / Chengdu Kanghong Pharma
Trial initiation date, Metastases: Phase 1 Trial of KH617 (clinicaltrials.gov) - Jan 19, 2023
P1, N=45, Recruiting, Sponsor: Sichuan Honghe Biotechnology Co., Ltd.
Initiation date: Dec 2023 --> Dec 2022
- | KH617 / Chengdu Kanghong Pharma
New P1 trial, Metastases: Phase 1 Trial of KH617 (clinicaltrials.gov) - Dec 28, 2022
P1, N=45, Recruiting, Sponsor: Sichuan Honghe Biotechnology Co., Ltd.